Trial Details
COMPLETEDBasic Information
| Clinical ID | c1535 |
|---|---|
| Identifier | NCT00616434 |
| Trial Title | A Phase 2 Study of Interferon Beta-1a (Avonex) in Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Active Ulcerative Colitis |
| Interventions | DRUG: BG9418 (Interferon beta-1a)|DRUG: Placebo |
Participant Information
| Sponsor | Biogen |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2025-05-08 |
|---|---|
| Primary Completion Date | 2025-03-10 |
| Completion Date | 2025-03-10 |